The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) created the Drug-Induced Liver Injury (DILI) Network to collect and analyze cases of severe liver injury caused by prescription drugs, herbal products and supplements.
In the last decade, considerable time and resources have been devoted to hepatitis C research, leading to significant treatment breakthroughs.
Six cutting-edge abstracts will be presented during Sunday afternoon’s AASLD Plenary Session, which will be moderated by AASLD President Anna S. Lok, MD, FAASLD, and AASLD Secretary Kimberly A. Brown, MD, FAASLD.
Four experts will help clinicians take the uncertainty out of the diagnosis and management of incidental liver lesions during Monday’s DDW® Clinical Symposium, Incidental Liver
Expert teams will tackle two of the most controversial topics in hepatology and GI endoscopy during Monday’s AASLD Academic Debates session, providing attendees with a
A recent analysis published in the journal HEPATOLOGY suggests that the global prevalence of nonalcoholic fatty liver disease (NAFLD) is about 25 percent. According to
Welcome to Chicago, IL and Digestive Disease Week® (DDW) 2017! Here you will attend the first and foremost GI event in the world over the next four days. Included
ABIM is inviting Digestive Disease Week® (DDW) 2017 attendees to a focus-group style discovery session in Chicago. During the session, you will discuss what the
The DDW® 2017 mobile planner is live! Consisting of the online planner and mobile app, these comprehensive tools place the meeting in an easy to navigate,
Stop by the tech desk to inquire about all of DDW’s digital platforms, including the DDW Mobile App, gamification, social media channels, ePosters and DDW